
    
      A 24 hour pharmacokinetic investigation of atorvastatin and metabolites will be performed in
      15 patients with a history of atorvastatin -induced myotoxicity. The possible link to
      relevant mutations in SLCO1B1, CYP3A5 and MDR1 will be also be investigated
    
  